Fig. 5From: Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcomaAdaptation at fraction 1 (B) to account for tumor growth from the time of simulation (A). Solid green line represents GTV at time of simulation and dotted green line represents GTV at time of fraction 1Back to article page